A form of anemia characterized by functional iron deficiency despite adequate or elevated iron stores, occurring secondary to chronic inflammation, infection, autoimmune disease, or malignancy. The condition results from immune-mediated sequestration of iron within macrophages and reduced intestinal absorption, driven primarily by hepcidin upregulation in response to IL-6 signaling. This creates a paradox: the body has sufficient stored iron but cannot access it for erythropoiesis.
Imagine a city with warehouses full of building materials (iron stores), but all the roads leading out are blocked by security gates (hepcidin blocking ferroportin). Construction crews building new houses (red blood cells) can't get the steel beams they need, so production slows to a crawl. The security team (immune system) deliberately locked the gates because there's a perceived threat—invaders (pathogens) who also need steel to build their own structures. The warehouses are actually getting fuller (elevated ferritin) because delivery trucks can still bring materials in, but nothing can leave. Meanwhile, the construction foreman (erythropoietin) is shouting orders that the crews increasingly ignore because the inflammatory alarm bells (cytokines) are drowning him out. The city's defense strategy is working—the invaders can't get building materials—but the construction industry grinds to a halt as collateral damage. This is evolutionarily ancient: better to be anemic and alive than well-oxygenated and dead from infection.
The pathophysiology of anemia of chronic disease involves multiple interconnected pathways:
graph TD
A[Chronic Inflammation/Infection] --> B["IL-6/IL-1/TNF-α Production"]
B --> C[Hepatic Hepcidin Synthesis]
C --> D[Hepcidin Binds Ferroportin]
D --> E[Ferroportin Internalization & Degradation]
E --> F1[Blocked Intestinal Iron Absorption]
E --> F2[Iron Trapped in Macrophages]
E --> F3[Iron Trapped in Hepatocytes]
F1 --> G[Functional Iron Deficiency]
F2 --> G
F3 --> G
B --> H[Direct Erythropoiesis Suppression]
H --> I[Reduced EPO Production]
H --> J[Decreased Erythroid Progenitor Sensitivity]
B --> K[Shortened RBC Lifespan]
G --> L[Anemia Despite Normal/High Ferritin]
I --> L
J --> L
K --> L
Primary pathway (hepcidin-ferroportin axis):
- Chronic inflammation or infection stimulates production of IL-6, IL-1, and TNF-α by activated macrophages, dendritic cells, and other immune cells
- IL-6 binds IL-6 receptor on hepatocytes → activates JAK-STAT3 signaling → upregulates HAMP gene transcription
- Hepatocytes synthesize and secrete hepcidin (a 25-amino acid antimicrobial peptide) into circulation
- Hepcidin binds to ferroportin (SLC40A1), the sole cellular iron exporter, on three critical cell types:
- Duodenal enterocytes (blocks dietary iron absorption)
- Macrophages in liver, spleen, bone marrow (blocks iron recycling from senescent erythrocytes)
- Hepatocytes (blocks iron mobilization from storage)
- Ferroportin binding triggers its ubiquitination, endocytosis, and lysosomal degradation
- Cellular iron becomes trapped inside cells, unavailable for transferrin binding and delivery to erythroid precursors
Secondary mechanisms:
Evolutionary rationale:
This represents nutritional immunity—an ancient defense strategy where the host sequesters essential nutrients (iron, zinc) from pathogens. Most bacteria require iron for replication (as cofactor for ribonucleotide reductase, electron transport enzymes). By withholding iron, the immune system creates a metabolically hostile environment. The trade-off is reduced oxygen-carrying capacity, but this is preferable to uncontrolled infection.
Patient populations:
Anemia of chronic disease is the second most common anemia worldwide (after iron deficiency) and occurs in:
cPNI Framework Connections:
- Selfish Immune System: The immune system prioritizes its own survival imperatives over oxygen delivery, demonstrating the hierarchy where defense trumps metabolic optimization. The selfish immune system "steals" iron for its anti-pathogen strategy.
- Evolutionary Mismatch: Modern chronic low-grade inflammation (triggered by processed foods, sedentarism, psychological stress) inappropriately activates an ancient anti-infection program. The body responds to metabolic inflammation as if facing infection, creating anemia without the evolutionary justification.
- Systems Interaction: Demonstrates immune-metabolism crosstalk via hepcidin regulation, and neuro-immune-metabolic integration through IL-6's multiple systemic effects
Diagnostic approach:
- Ferritin >100 ng/mL (often 200-500 ng/mL) despite anemia—distinguishes from true iron deficiency (ferritin <30 ng/mL)
- Low serum iron (typically <60 ÎĽg/dL)
- Low total iron-binding capacity (TIBC) or transferrin—opposite of iron deficiency where TIBC is elevated
- Transferrin saturation <20% (ratio of serum iron to TIBC)
- Elevated C-reactive protein (CRP >10 mg/L) or erythrocyte sedimentation rate (ESR >30 mm/hr) confirms inflammatory state
- Hemoglobin typically 9-11 g/dL (mild-moderate anemia)
- Normocytic or mildly microcytic red cells (MCV 75-90 fL)
Intervention strategy:
- Primary target: Treat underlying inflammatory condition—antibiotics for infection, disease-modifying therapy for autoimmune disease, tumor treatment for malignancy
- Iron supplementation is generally contraindicated: Oral iron absorption is blocked by hepcidin, and providing iron to pathogens or cancer cells may worsen outcomes by fueling their metabolism
- Exception: In combined deficiency (true depletion plus inflammation), intravenous iron may bypass hepcidin blockade, but requires careful monitoring
- Anti-inflammatory interventions: Omega-3 fatty acids (EPA/DHA 2-4 g/day) reduce IL-6 production, curcumin inhibits NF-ÎşB-mediated cytokine transcription, vitamin D (target 40-60 ng/mL) modulates immune responses
- EPO therapy: Recombinant erythropoietin (40,000-60,000 units/week) can overcome cytokine-induced resistance in chronic kidney disease or cancer-related anemia
- Address lifestyle factors: Exercise reduces chronic low-grade inflammation, sleep optimization normalizes immune-metabolic regulation, stress reduction lowers cortisol-mediated immune dysregulation
- Second most common anemia globally, affecting 30-60% of patients with chronic inflammatory conditions
- Hepcidin has a half-life of 1-3 hours but rapidly degrades ferroportin, creating sustained effects
- IL-6 threshold for hepcidin induction is approximately 7-10 pg/mL (normal <5 pg/mL)
- Ferritin is an acute phase protein—can be elevated by inflammation independent of iron stores; every 10 mg/L increase in CRP raises ferritin by approximately 30 ng/mL
- In combined iron deficiency and ACD, soluble transferrin receptor (sTfR) >8 mg/L suggests true depletion
- TNF-α suppresses EPO production at concentrations >50 pg/mL (normal <8 pg/mL)
- Anemia correlates with disease severity—each 1 g/dL drop in hemoglobin increases mortality risk by 15% in heart failure patients
- Red blood cell life expectancy reduced from 120 days to 80-90 days in active inflammation
- Hepcidin gene (HAMP) expression can increase 100-fold within 6 hours of IL-6 exposure
- Evolutionary conservation: hepcidin-ferroportin system exists in fish, suggesting >400 million years of selection pressure
- hepcidin — master regulator whose IL-6-driven upregulation is the primary mechanism causing ACD by degrading ferroportin
- ferroportin — sole cellular iron exporter that becomes ubiquitinated and destroyed when hepcidin binds, trapping iron intracellularly
- IL-6 — principal inflammatory cytokine stimulating hepatic hepcidin synthesis via JAK-STAT3 pathway, with synergistic effects from IL-1
- chronic inflammation — underlying driver producing sustained elevations of IL-6, TNF-α, and IL-1 that trigger all ACD mechanisms
- ferritin — iron storage protein paradoxically elevated in ACD (>100-500 ng/mL) because it's both storing sequestered iron and acting as acute phase protein
- iron — essential micronutrient that becomes functionally unavailable despite adequate total body stores due to sequestration strategy
- macrophages — trap iron from phagocytosed senescent erythrocytes and cannot release it when ferroportin is degraded by hepcidin
- erythropoietin — renal hormone whose production is suppressed by TNF-α and IL-1, and whose erythroid progenitor effects are blocked by SOCS3
- TNF-α — inflammatory cytokine that suppresses EPO production, induces erythroid precursor apoptosis, and stimulates hepcidin independently of IL-6
- nutritional immunity — evolutionary defense strategy where host sequesters essential nutrients from pathogens; ACD represents the anemia cost of this strategy
- transferrin — iron transport protein with low saturation (<20%) in ACD because iron cannot exit storage cells to bind it
- chronic low-grade inflammation — modern mismatch condition (obesity, metabolic syndrome) inappropriately activating ancient anti-infection iron sequestration
- rheumatoid arthritis — archetypal autoimmune disease causing ACD through sustained IL-6 production by inflamed synovium; 30-60% prevalence
- inflammatory bowel disease — chronic intestinal inflammation produces ACD via IL-6/TNF-α while also impairing iron absorption through damaged mucosa
- infection — acute or chronic infections (tuberculosis, endocarditis, HIV) trigger ACD as evolutionary defense to withhold iron from pathogens
- siderophores — bacterial iron-scavenging molecules (e.g., enterobactin) that ACD helps protect against by keeping iron locked in mammalian cells
- C-reactive protein — acute phase protein marker (>10 mg/L) confirming inflammatory state and correlating with ferritin elevation independent of iron
- cancer — many malignancies produce inflammatory cytokines (IL-6, IL-1) directly or via tumor-associated macrophages, causing ACD in 30-50% of patients
- fatigue — cardinal symptom in ACD patients, resulting from reduced oxygen delivery but also direct cytokine effects on brain metabolism and motivation circuits
- hypoxia — tissue oxygen deficit created by anemia triggers HIF stabilization attempting to stimulate EPO, but inflammatory cytokines block this compensatory response
- Supplementation — iron supplementation paradoxically ineffective and potentially harmful in ACD, distinguishing intervention from true iron deficiency anemia
- obesity — adipose tissue macrophages produce IL-6 and TNF-α, creating chronic low-grade inflammation that can trigger mild ACD even without overt disease
- selfish immune system — theoretical framework explaining why immune system prioritizes iron sequestration for pathogen defense over erythropoiesis for oxygen delivery
- acute phase response — coordinated liver protein synthesis changes including ferritin upregulation and transferrin downregulation during inflammation
- anemia — ACD represents specific subtype characterized by inflammation-driven functional iron deficiency rather than absolute depletion